Lim J T, Tham S N
National Skin Centre, Singapore.
Ann Acad Med Singap. 1994 Nov;23(6):848-51.
In the last 30 years, methotrexate has been used for treating psoriasis, rheumatoid arthritis and other inflammatory disorders. Much has been learned about its beneficial and adverse effects. Long-term use produces different effects from short-term use. This study was undertaken to study the long-term use of methotrexate in our local population. It is a retrospective study where the case reports of 72 psoriatic patients on methotrexate were analysed for its use, side effects, the monitoring of side effects and its efficacy. Our study showed that methotrexate was effective in 61 (86.0%) patients, had some side effects in 10 (14.2%) patients and was relatively safe. It also helped psoriatic arthropathy. However, adequate and close monitoring is required to prevent liver fibrosis and cirrhosis.
在过去30年里,甲氨蝶呤一直被用于治疗银屑病、类风湿性关节炎和其他炎症性疾病。人们对其有益和不良影响已有很多了解。长期使用与短期使用产生的效果不同。本研究旨在探讨甲氨蝶呤在我们当地人群中的长期使用情况。这是一项回顾性研究,分析了72例使用甲氨蝶呤的银屑病患者的病例报告,包括用药情况、副作用、副作用监测及其疗效。我们的研究表明,甲氨蝶呤对61例(86.0%)患者有效,10例(14.2%)患者有一些副作用,且相对安全。它对银屑病关节炎也有帮助。然而,需要进行充分且密切的监测以预防肝纤维化和肝硬化。